SocialEyes
HEALTHCARE THAT SCALES
Anywhere and Everywhere
New forms of healthcare services are needed at enormous scale
Welcome to "the edge"
where billions of people still live, beyond the reach of critically-needed medical care. Hundreds of millions now need specialist attention that's in short supply everywhere—let alone in the low-resource societies where most cases are occurring.
HEALTHCARE ISN’T SCALING
Conventional medicine has yet to take full advantage of widely-available technology to reach high-risk populations. While telehealth has many benefits, it generally replicates existing workflow without fundamental innovation: Highly-trained humans are still involved in every case.
Barriers to access
Ironically, one of the biggest obstacles to getting the right care to the right person at the right time, is today's referral-based healthcare system. Even in advanced societies, most patients simply don’t follow through, let alone adhere to "best practice" regimes that typically involve multiple visits to a specialist.
Adding the limited availability of tertiary care outside urban centers, transportation costs, and reluctance to leave home, to a long list of barriers, doing without sets the scene for enormous social cost and suffering.
VISION
The human retina contains a wealth of diagnostic markers for many non-communicable diseases, such as diabetes and hypertension, as well as infectious conditions such as tuberculosis, HIV, dengue and malaria.
Unlocking its secrets presently requires the skills of ophthalmological specialists, who are in short supply everywhere.
SOCIALEYES INVENTED MARVIN—MOBILE AUTONOMOUS RETINAL EVALUATION—TO BRING CRITICALLY-NEEDED MEDICAL SERVICES TO “THE EDGE”, AND EVERYWHERE ELSE
MARVIN is the foundation for a new, scalable healthcare “platform” that upgrades the capabilities of primary care. In the case of diabetic retinopathy, for example, MARVIN helps general practitioners, and ultimately, community healthcare workers, spot retinal changes that can trigger early intervention.
Marginal image quality is common in low-resource settings, especially with non-mydriatic (undilated) imaging.
SocialEyes technology, running on mobile supercomputer tablets, makes key retinal features easier to see.
Neural nets and machine learning help ensure that high-risk cases are caught right at the point of initial contact.
EMPOWER
Although the world’s supply of eye specialists is limited, there are over 15,000,000 general practitioners—and even more nurses, support staff and community health workers—who can use SocialEyes and MARVIN to manage their patients in primary care.
GROWING GAPS IN CARE
A VERY BIG PROBLEM THAT NEEDS TO BE SOLVED
200,000
EYE DOCTORS WORLDWIDE ARE LOCATED PRIMARILY
IN URBAN SETTINGS
1 BILLION+
PERSONS WITH DIABETES, HYPERTENSION AND OTHER DISEASES ALL FACE PROBLEMS WITH THEIR VISION
SocialEyes builds capacity for nationwide and regional coverage, using existing healthcare facilities.
With MARVIN, doctors, ophthalmic assistants and community health workers can now make informed decisions in moments, while the patient is there. This encourages personalized counseling and education, as well as integrating advanced eye care with treating the systemic disease.
MARVIN
Mobile, autonomous, retinal evaluation is a unique approach to making specialized medical skills available at “the edge”, where they’re needed most.
MARVIN creates myriad points of access to “best practice” care, everywhere.
Most patients referred by community facilities can now be managed close to home, without having to refer them to tertiary eye care centers (if available) where underlying medical issues may not be addressed.
OUR INTENTION
Advanced assessment and diagnostic services in every village, town and urban neighborhood can build effective coverage across entire nations and regions.
And the knowledge from enormous amounts of rich, uniform and current data, collected from millions of cases, improves care for the one person presenting right now.
CONNECT
Bring SocialEyes to your country. Find out more about the future of healthcare, today.